Page last updated: 2024-12-08

tris(2,2'-bipyridyl)cobalt(iii)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tris(2,2'-bipyridyl)cobalt(III): RN given for (triperchlorate,(OC-6-11))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161059
MeSH IDM0306540

Synonyms (11)

Synonym
cobalt(3+), tris(2,2'-bipyridine-n,n')-, (oc-6-11)-, triperchlorate
cobalt(3+), tris(2,2'-bipyridine-n,n')-, perchlorate (1:3), (oc-6-11)-
tris(bipyridine)cobalt(iii) perchlorate
14376-02-4
tris(2,2'-bipyridyl)cobalt(iii)
tris(2,2'-bipyridyl)cobalt(iii) perchlorate
cobalt trisbipyridyl
cobpy cpd
DTXSID00162536
tris(2,2/'-bipyridyl)cobalt(iii)
cobalt(3+);2-pyridin-2-ylpyridine;triperchlorate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]